在爆款大单品的带动下，全球药企营收TOP10的榜单座次也发生了变化，礼来凭借替尔泊肽成为第九，而葛兰素史克则掉出榜单。机构预测，2030年全球抗肥胖药物市场整体规模有望达到1000亿美元。随着司美格鲁肽和替尔泊肽的销量狂飙，2025年的头部格局将如何 ...

Medically reviewed by Femi Aremu, PharmDCrestor (rosuvastatin) and Lipitor (atorvastatin) are the top medications for ...

Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

It was founded by Lipitor (atorvastatin calcium) codiscoverer Roger Newton, after his ideas for using synthetic high-density lipoprotein (HDL) derivatives as biopharmaceuticals were rejected by ...